FindTrial
Sign In

Is it safe and practicable to use an 18-Fr urinary catheter as chest tube for surgical lung cancer patients after lobectomy? a case records based study

the feasibility of 18-Fr chest tube for lung cancer patients undergoing video-assisted thoracoscopic surgery (VATS) lobectomy: a case records based study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800014816
Enrollment
Unknown
Registered
2018-02-07
Start date
2018-02-08
Completion date
Unknown
Last updated
2018-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

18-F group:inserting 18-Fr urinary catheter after surgery
28-F group:inserting 28-Fr chest tube after surgery

Sponsors

Guowei Che
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: The enrolled subjects consisted of surgical patients diagnosed with non-small cell lung cancer (NSCLC) admitted to the Thoracic Department of West China Hospital, a tertiary regional center. People who met the inclusive criteria including 1) diagnosed as NSCLC; 2) undergoing VATS lung cancer lobectomy; 3) age between 50-75 years old are eligible for enrollment; 4) with a informed consent.

Exclusion criteria

Exclusion criteria: 1. not NSCLC; 2. did not receieving VATS lung cancer lobectomy.

Design outcomes

Primary

MeasureTime frame
mean pain score (VAS score) while the chest tube was in situ;—

Secondary

MeasureTime frame
PPCs within 30 days;The output of the drains;chest tubes removal-related complications;—

Countries

China

Contacts

Public ContactGuowei Che

West China Hospital, Sichuan University

896828079@qq.com+86 15184338538

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 24, 2026